Delivery Order SPE2DR25D1017-SPE2DR26F9AVD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count) valued at $1,152.00. This firm fixed-price delivery order is scheduled for completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count) valued at $1,868.16. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100 count) with a ceiling value of $2,155.26 and a completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger federal contract vehicle. The performance location is the contractor's corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a contract value of $1,150.92. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive selection. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,013.83 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) on November 13, 2025, with completion scheduled for November 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,088.77. This firm fixed-price delivery order, with an ultimate completion date of October 24, 2025, represents a non-set-aside award issued through competitive procedures. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) valued at $1,024.34 with a firm fixed-price contract type. The order is non-set-aside and carries an ultimate completion date of December 10, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Dextroamphetamine-Amphetamine 30 mg capsules (100-count units) with a ceiling value of $1,021.84. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,129.10 and a firm fixed price structure. This competitive award, which carries no set-aside designation, is scheduled for completion by November 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AVDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a ceiling value of $1,048.97. This firm fixed price delivery order, with an ultimate completion date of December 5, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated significant capability across the Defense Logistics Agency's medical supply chain through numerous competitive contract awards. The company supplies an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for controlled substance pharmaceutical products further exemplifies AmerisourceBergen's role as a primary vendor supporting Defense Health Agency and broader federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 12/3/25 |